Tacrolimus Once-Daily Formulation: In the Prophylaxis of Transplant Rejection in Renal or Liver Allograft Recipients

By Cross Sarah A.   Perry Caroline M.  

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1931-1943

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation

By Benkali Khaled  

Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. : 683-692

Adis International

Access to resources Recommend Favorite

Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients

By Glowacki François   Lionet Arnaud  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 451-459

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Model to Predict Steady-State Exposure to Once-Daily Cyclosporin Microemulsion in Renal Transplant Recipients

By Schädeli F.   Marti H-P.   Frey F.J.   Uehlinger D.E.  

Clinical Pharmacokinetics, Vol. 41, Iss. 1, 2002-01 ,pp. : 59-69

Adis International

Access to resources Recommend Favorite

Antifungal prophylaxis benefits for liver transplant recipients analysed

By  

Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite